Science AI Journal
Medicine · Research topic

Open research questions in Gestational Diabetes Research and Management

759 gap statements mined from Gestational Diabetes Research and Management papers in our 7.9M-paper local library, which holds 3,296 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.

Choosing where to publish on Gestational Diabetes Research and Management? See the ranked Medicine journals.

What the literature leaves open

  • The study addresses the gap in understanding the associations between maternal weight change patterns in early pregnancy and infant neurodevelopment. The research highlights the need for further investigation into the impact of early-pregnancy weight loss and catch-up weight gain on neurodevelopmental outcomes in infants.

    Impact of early-pregnancy weight loss and catch-up weight gain on neurodevelopmental outcomes and trajectories in infants aged 0–3 years: the Beijing Birth Cohort Study · 2026 · DOI

  • The current research on miRNAs in GDM is still incomplete. There is a lack of systematic exploration of the clinical value and molecular mechanisms of specific miRNAs. There is a need to identify potential diagnostic and prognostic biomarkers for GDM.

    miR-1180-5p as a potential biomarker for the standard diagnosis of gestational diabetes and its correlation with pregnancy outcomes · 2026 · DOI

  • Prior studies have shown that GDM can alter maternal hemodynamic changes, but the specific relationship between GDM phenotypes and hemodynamics is not well understood. The study aims to address this gap by analyzing the hemodynamic changes in women with different GDM phenotypes.

    Different gestational diabetes phenotypes: which relationship with maternal hemodynamics? · 2026 · DOI

  • There is a lack of systematic investigation into the differences in effects of surgical and spontaneous fetal reduction on subsequent pregnancy outcomes. The study aims to fill this gap by comparing maternal and neonatal outcomes among the three groups.

    Impact of surgical versus spontaneous fetal reduction on maternal and neonatal outcomes after assisted reproductive technology: a single-center cohort study of 1, 451 singleton live births · 2026 · DOI

  • The contribution of emerging adipokines, including neuregulin-4 (NRG4) and isthmin-1 (ISM1), to the fetal adipokine profile remains incompletely understood.

    Altered umbilical cord adipokine profile associated with maternal obesity: an exploratory cohort study · 2026 · DOI

  • The study highlights the need to consider pregnant women's experiences, perceptions, and concerns related to body changes during pregnancy, beyond an exclusive focus on monitoring gestational weight gain. The study identifies a gap in the current understanding of the relationships among attitudes toward gestational weight gain, internalized weight bias in pregnancy, and exercise avoidance tendencies.

    Attitudes toward gestational weight gain and exercise avoidance tendencies: a latent profile analysis and mediation test of internalized weight bias in pregnant women · 2026 · DOI

  • The current diagnosis of GDM relies on the oral glucose tolerance test, which may not capture metabolic disturbances that precede this window. There is a need for improved strategies for early risk identification and preventive intervention. The relationship between dietary patterns and GDM is not well understood, particularly in the context of serum proteomics.

    A processed dietary pattern is associated with gestational diabetes mellitus and altered APOM and SAA4 proteomic signatures in Miao women · 2026 · DOI

  • There is a need for a comprehensive understanding of the pathophysiology of gestational diabetes mellitus. The current literature lacks a detailed overview of the role of placental hormones and signaling in GDM. Further research is needed to elucidate the hormonal regulation and hypothalamic dysfunction in GDM.

    Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management · 2025 · DOI

  • The study notes that most studies on biomarkers for GDM have been conducted during the second trimester, which may limit the generalizability of the findings. The paper highlights the need for a multi-marker approach to improve risk stratification and guide personalized management strategies.

    Predictive Utility of Biochemical Markers for the Diagnosis and Prognosis of Gestational Diabetes Mellitus · 2024 · DOI

  • Formal cross-cultural validation of the 5-point format is recommended in future work.

    Attitudes toward gestational weight gain and exercise avoidance tendencies: a latent profile analysis and mediation test of internalized weight bias in pregnant women · 2026 · DOI

  • High glucose induced only modest cytokine responses, suggesting that acute exposure alone is insufficient for robust inflammasome activation.

    Metabolic, microbial, and pharmacological stimuli elicit distinct lipidomic and cytokine responses in the human placenta · 2026 · DOI

  • While women's experiences of GDM have been linked with healthcare professionals (HCPs) and healthcare system factors, there is limited knowledge of HCPs perspectives on current GDM care.

    Health-Care Providers' Perspectives on Information, Care, and Support for Women With Gestational Diabetes Mellitus: Insights From a Qualitative Study · 2026 · DOI

  • Betatrophin has been implicated in glucose metabolism, but its role in pregnancies complicated by GDM remains unclear.

    Cord blood betatrophin and insulin levels in term neonates born to mothers with gestational diabetes: A comparative crosssectional study: doi: 10.7417/CT.2026.2155 · 2026

  • Maternal diabetes is linked to adverse perinatal outcomes, but its association with neurodevelopmental delays in offspring remains unclear.

    Neurodevelopmental outcomes of children born to diabetic mothers in the Qatari population: a retrospective study · 2026 · DOI

  • Introduction Elevated maternal body mass index (BMI) during pregnancy is associated with adverse maternal and offspring outcomes; yet the molecular pathways linking maternal metabolic status to placental function and fetal immune development remain poorly understood.

    Maternal late-pregnancy BMI is associated with compartment-specific immune-metabolic signatures across the maternal–placental–fetal axis · 2026 · DOI

  • Remnant cholesterol (RC) is a known contributor to cardiovascular disease, but its role in gestational diabetes mellitus (GDM) remains insufficiently characterized.

    Early-pregnancy remnant cholesterol as a modifiable risk factor for gestational diabetes mellitus · 2026 · DOI

  • Investigate the effects of MFPR on subsequent pregnancy outcomes. Examine the risk levels of MFPR compared with the initial singleton pregnancy population. Study the differences in the effects of surgical and spontaneous reduction modalities on pregnancy outcomes.

    Impact of surgical versus spontaneous fetal reduction on maternal and neonatal outcomes after assisted reproductive technology: a single-center cohort study of 1, 451 singleton live births · 2026 · DOI

  • Limited number of dysglycaemic events, - Number of covariates included in the multivariate model was restricted to minimize overfitting, - No significant differences found in body composition parameters…

    One year after gestational diabetes: metabolic changes and predictors of postpartum dysglycaemia · 2026 · DOI

  • Investigating the role of insulin therapy in predicting glucose impairment, - Examining the effects of lifestyle interventions on glycaemic outcomes, - Studying the relationship between breastfeeding and glucose…

    One year after gestational diabetes: metabolic changes and predictors of postpartum dysglycaemia · 2026 · DOI

  • Lack of RCTs, - Very low/low certainty evidence, - Difficulty in research design in labor and delivery, - Limited evidence for the use of Glucagon-like Peptide-1 receptor agonists (GLP-1s)…

    Preexisting diabetes and pregnancy: reflections on the joint guidelines of the Endocrine Society and European Society of Endocrinology · 2026 · DOI

  • Need for more research into optimal glycemic targets, especially at night, - Need for more research on the use of Glucagon-like Peptide-1 receptor agonists (GLP-1s) preconception, - Need for more research on the safety of Tirzepatide…

    Preexisting diabetes and pregnancy: reflections on the joint guidelines of the Endocrine Society and European Society of Endocrinology · 2026 · DOI

  • The study had a relatively limited sample size of the proteomics subset (n = 78) - The preprocessing step did not fit a predictive model and incorporated GDM group information, which may introduce optimism related to outcome-informed upstream preprocessing - The study cannot completely exclude optimism related to outcome-informed upstream…

    A processed dietary pattern is associated with gestational diabetes mellitus and altered APOM and SAA4 proteomic signatures in Miao women · 2026 · DOI

  • Further studies are needed to investigate the long-term effects of GDM on the mother and child, - The role of other inflammatory pathways in GDM should be investigated, - The effectiveness of inhibitors in reducing the inflammatory response in GDM patients should be further…

    Gestational Diabetes Mellitus-Induced Inflammation in the Placenta via IL-1β and Toll-like Receptor Pathways · 2024 · DOI

  • The paper identifies a gap in understanding the pathomechanism of GDM, particularly the role of chronic, sterile, pro-inflammatory pathways. The study aims to evaluate the expression and regulation of the elements of IL-1β and Toll-like receptor pathways in GDM maternal blood plasma, healthy placental explants and a choriocarcinoma cell line.

    Gestational Diabetes Mellitus-Induced Inflammation in the Placenta via IL-1β and Toll-like Receptor Pathways · 2024 · DOI

  • Investigation of metabolites, microRNAs, and proteins implicated in insulin resistance, glucose metabolism, and inflammation, - Development of a multi-marker approach for GDM diagnosis and prognosis, - Further research on the predictive value of biomarkers in different…

    Predictive Utility of Biochemical Markers for the Diagnosis and Prognosis of Gestational Diabetes Mellitus · 2024 · DOI

Most-cited papers in Gestational Diabetes Research and Management

Most recent work

Find a gap in your own Gestational Diabetes Research and Management sub-topic

This page shows what the Gestational Diabetes Research and Management literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
4,200 open questions
Dementia and Cognitive Impairment Research
2,789 open questions
Substance Abuse Treatment and Outcomes
2,285 open questions
Cancer Immunotherapy and Biomarkers
2,273 open questions
Liver Disease Diagnosis and Treatment
2,102 open questions
Sports Performance and Training
1,952 open questions
Parkinson's Disease Mechanisms and Treatments
1,915 open questions
Mosquito-borne diseases and control
1,849 open questions
Open questions raised by papers listed on this page include: (1) There is a lack of systematic exploration of the clinical value and molecular mechanisms of specific miRNAs (“miR-1180-5p as a potential biomarker for the standard diagnosis of gestational…”, 2026); (2) Prior studies have shown that GDM can alter maternal hemodynamic changes, but the specific relationship between GDM phenotypes and hemodynamics is not well understood (“Different gestational diabetes phenotypes: which relationship with maternal…”, 2026); (3) There is a lack of systematic investigation into the differences in effects of surgical and spontaneous fetal reduction on subsequent pregnancy outcomes (“Impact of surgical versus spontaneous fetal reduction on maternal and neonatal…”, 2026); (4) The contribution of emerging adipokines, including neuregulin-4 (NRG4) and isthmin-1 (ISM1), to the fetal adipokine profile remains incompletely understood (“Altered umbilical cord adipokine profile associated with maternal obesity: an…”, 2026); (5) There is a need for improved strategies for early risk identification and preventive intervention (“A processed dietary pattern is associated with gestational diabetes mellitus…”, 2026). 759 gap statements have been mined from Gestational Diabetes Research and Management papers in our 7.9M-paper local library, which holds 3,296 papers on the topic; the gaps come from whichever of those papers state one. They are mostly the research gaps the authors state and the papers' abstracts, plus future-work, limitations and challenges passages. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 1,100,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? Acceptance odds for top, mid and open/emerging journals, in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck for prior publication across 7 sources and our local library.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.